Hybrisan
Hybrisan is a MedTech company based in South Wales dedicated to solving problems of bioburden and biofilm in healthcare and chronic wound treatment. They develop innovative solutions like the WoundSan® platform to revolutionize global wound care, aiming for a world without chronic infection. Their mission is to provide ethical, affordable, and superior technological solutions for infection control, improving lives impacted by chronic wounds.
Industries
Nr. of Employees
small (1-50)
Hybrisan
Products
Irrigation solution for wound cleansing with antimicrobial and antibiofilm activity
A wound irrigation formulation intended for cleansing and moistening acute and chronic wounds; designed to mechanically assist removal of slough and biofilm and tested in vitro against multispecies biofilms.
Irrigation solution for wound cleansing with antimicrobial and antibiofilm activity
A wound irrigation formulation intended for cleansing and moistening acute and chronic wounds; designed to mechanically assist removal of slough and biofilm and tested in vitro against multispecies biofilms.
Services
End-to-end product design and development activities including formulation, nanofibre prototyping and optimisation to production-ready prototypes.
Laboratory testing services including inhibitory and bactericidal concentration testing, biofilm eradication assays and mechanism-of-action studies in a BSL-2 environment.
Manufacture of nanofibre products using industrially acceptable electrospinning processes and equipment, with capacity for optimisation to production-ready throughput.
Quality control processes based on Quality by Design principles and support for regulatory readiness of antimicrobial and device products.
End-to-end product design and development activities including formulation, nanofibre prototyping and optimisation to production-ready prototypes.
Laboratory testing services including inhibitory and bactericidal concentration testing, biofilm eradication assays and mechanism-of-action studies in a BSL-2 environment.
Manufacture of nanofibre products using industrially acceptable electrospinning processes and equipment, with capacity for optimisation to production-ready throughput.
Quality control processes based on Quality by Design principles and support for regulatory readiness of antimicrobial and device products.
Expertise Areas
- Antimicrobial and antibiofilm research
- Wound care product development
- Nanofibre materials and electrospinning
- Microbiology and in vitro biofilm testing
Key Technologies
- Electrospinning (nanofibres)
- In vitro multispecies biofilm assays
- Scanning electron microscopy (SEM)
- Antimicrobial formulation development
News & Updates
Hybrisan announced a new milestone in their development, showcasing their progress and innovation in wound care solutions.
Hybrisan announced a new milestone in their development, showcasing their progress and innovation in wound care solutions.